Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-24 @ 10:32 PM
NCT ID:
NCT05878535
Eligibility Criteria:
Inclusion Criteria:
* Willing and able to provide written informed consent prior to performing study procedures.
* Atrial fibrillation (first detected, paroxysmal, persistent, longstanding persistent, or permanent)\*.
\* Types of atrial fibrillation:
* First detected: only one diagnosed episode.
* Paroxysmal: recurrent episodes that stop on their own in less than seven days.
* Persistent: recurrent episodes that last more than seven days.
* Longstanding persistent: recurrent episodes that last more than twelve months.
* Permanent: atrial fibrillation that has been accepted, and for which a solely rate control strategy has been decided upon.
Exclusion Criteria:
* Critically-ill patients who are admitted to ICU.
* Advanced congestive heart failure.
* Liver cell failure.
* Chronic kidney disease with eGFR \<45 mL/min/1.73 m².
* Diabetic ketoacidosis with or without coma.
* Concomitant treatment with carbonic anhydrase inhibitors.
* Septicemia.
* Shock.
* Hypoxia.
* Dehydration.
* Blood Dyscrasias.
* Alcoholism.
* Pregnancy.
* Lactation.
* Chronic muscle diseases.
* Acute trauma or burns within 2 weeks.
* History of allergy to the implemented drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT05878535
Study Brief:
Protocol Section:
NCT05878535